Imatinib 400 mg contains Imatinib Mesylate, a tyrosine kinase inhibitor used in the treatment of certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
Indications: Chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs).
Dosage: 400 mg to 600 mg daily, depending on the condition being treated.
Side Effects: Nausea, vomiting, muscle cramps, rash, fatigue.
Precautions: Regular monitoring of blood counts and liver function is necessary. Use with caution in patients with hepatic impairment.
Storage: Store at room temperature, away from moisture and light.
| Form | Tablets |
| Salt Composition | Imatinib Mesylate |
| Brand Name | Imatib |
| Medicine Type | Allopathic |
| Strength | 400 Mg |
| Dosage | As Directed By Oncologist |
| Storage | Store Below 30°C |
| Treatment | Cancer |
| Caution | Keep Out Of Each Of Children |
| Action Class | Tyrosine Kinase Inhibitors |
| Shelf Life | As Per The Expiry Date Provided On Package |
| Application | Hospital Use |
| Indication | Chronic Myeloid Leukemia |
| Packing Material | Blister Pack Of 30 Tablet |
| Exporter By | Medicina Overseas Private Limited |
| Country Of Origin | India |
